NATIONAL INSTITUTES OF HEALTH
- Country
- 🇺🇸United States
- Ownership
- Subsidiary, Private
- Established
- 1948-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.nidcr.nih.gov
Randomized Trial of EUS Neurolysis in Pancreas Cancer
- Conditions
- Pancreatic Neoplasms
- First Posted Date
- 2006-01-19
- Last Posted Date
- 2015-10-14
- Target Recruit Count
- 26
- Registration Number
- NCT00279292
- Locations
- 🇺🇸
Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic Jacksonville, Jacksonville, Florida, United States
TEDDY - The Environmental Determinants of Diabetes in the Young
- Conditions
- Type 1 Diabetes Mellitus
- First Posted Date
- 2006-01-19
- Last Posted Date
- 2024-11-25
- Target Recruit Count
- 8667
- Registration Number
- NCT00279318
- Locations
- 🇫🇮
Wellbeing Services County of Southwest Finland, Turku, Finland
🇺🇸University of Colorado Health Sciences Center, Denver, Colorado, United States
🇺🇸Augusta University, Augusta, Georgia, United States
Cediranib Maleate in Treating Patients With Persistent, Recurrent, or Refractory Advanced Ovarian Epithelial, Peritoneal Cavity, or Fallopian Tube Cancer
- Conditions
- Recurrent Fallopian Tube CancerRecurrent Ovarian Epithelial CancerRecurrent Primary Peritoneal Cavity Cancer
- Interventions
- Other: laboratory biomarker analysis
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2018-08-29
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 74
- Registration Number
- NCT00278343
- Locations
- 🇺🇸
City of Hope Medical Group Inc, Pasadena, California, United States
🇺🇸City of Hope, Duarte, California, United States
🇺🇸Ingalls Memorial Hospital, Harvey, Illinois, United States
Vorinostat in Treating Patients With Kidney Cancer
- Conditions
- Recurrent Renal Cell CarcinomaStage IV Renal Cell Cancer
- Interventions
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2017-11-14
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 14
- Registration Number
- NCT00278395
- Locations
- 🇺🇸
Institute for Drug Development, San Antonio, Texas, United States
🇺🇸Cancer Therapy and Research Center at The UT Health Science Center at San Antonio, San Antonio, Texas, United States
Radiation Therapy in Treating Patients With Cervical Cancer
- Conditions
- Cervical Cancer
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2013-06-20
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 20
- Registration Number
- NCT00278304
- Locations
- 🇺🇸
Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support, Bethesda, Maryland, United States
Flavopiridol and Vorinostat in Treating Patients With Relapsed or Refractory Acute Leukemia or Chronic Myelogenous Leukemia or Refractory Anemia
- Conditions
- Blastic Phase Chronic Myelogenous LeukemiaRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Adult Acute Myeloid LeukemiaRefractory Anemia With Excess BlastsRelapsing Chronic Myelogenous LeukemiaUntreated Adult Acute Lymphoblastic LeukemiaUntreated Adult Acute Myeloid Leukemia
- Interventions
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2013-04-02
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 24
- Registration Number
- NCT00278330
- Locations
- 🇺🇸
Virginia Commonwealth University, Richmond, Virginia, United States
Sorafenib in Treating Patients With Recurrent Non-Hodgkin's Lymphoma
- Conditions
- Anaplastic Large Cell LymphomaRecurrent Mantle Cell LymphomaRecurrent Adult Diffuse Large Cell Lymphoma
- Interventions
- Other: laboratory biomarker analysis
- First Posted Date
- 2006-01-18
- Last Posted Date
- 2013-02-07
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 33
- Registration Number
- NCT00278382
- Locations
- 🇺🇸
University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, United States
Temsirolimus in Treating Patients With Metastatic Solid Tumor or Lymphoma That Cannot Be Removed By Surgery Who Have Different Levels of Liver Function
- Conditions
- Hepatic ComplicationsLymphomaUnspecified Adult Solid Tumor, Protocol Specific
- Interventions
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2013-01-30
- Lead Sponsor
- National Cancer Institute (NCI)
- Target Recruit Count
- 130
- Registration Number
- NCT00275093
- Locations
- 🇺🇸
Cancer Therapy and Research Center at The UT Health Science Center at San Antonio, San Antonio, Texas, United States
Insulin Resistance in Severely Obese Patients
- Conditions
- ObesityInsulin ResistanceDiabetes
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2010-03-18
- Target Recruit Count
- 48
- Registration Number
- NCT00275223
- Locations
- 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
Glomerular Injury of Preeclampsia
- Conditions
- Pre-Eclampsia
- First Posted Date
- 2006-01-11
- Last Posted Date
- 2010-01-14
- Target Recruit Count
- 45
- Registration Number
- NCT00275158
- Locations
- 🇺🇸
Stanford University Medical Center, Stanford, California, United States